VAL-083

VAL-083 is an alkylating agent that creates N7 methylation on DNA, with antitumor activity.

Product Specifications

CAS Number

[23261-20-3]

Product Name Alternative

Dianhydrodulcitol; Dianhydrogalactitol

UNSPSC

12352005

Target

DNA Alkylator/Crosslinker

Type

Reference compound

Related Pathways

Cell Cycle/DNA Damage

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/val-083.html

Purity

98.0

Solubility

H2O : 70 mg/mL (ultrasonic)

Smiles

O[C@H]([C@H](O)[C@]1(OC1)[H])[C@@]2([H])CO2

Molecular Formula

C6H10O4

Molecular Weight

146.14

References & Citations

[1]Kaiji Hu, et al. Abstract 811: VAL083, a novel N7 alkylating agent, surpasses NSC 362856 activity and inhibits cancer stem cells providing a new potential treatment option for glioblastoma multiforme. Cancer Research. 2012 Mar 31-Apr 4.|[2]Jiang X, et al. Dianhydrogalactitol, a potential multitarget agent, inhibits glioblastoma migration, invasion, and angiogenesis. Biomed Pharmacother. 2017 Jul;91:1065-1074.|[3]Peng C, et al. 1,2:5,6-dianhydrogalactitol inhibits human glioma cell growth in vivo and in vitro by arresting the cell cycle at G2/M phase. Acta Pharmacol Sin. 2017 Apr;38 (4) :561-570.